Tissue specific oxidative stress profile in relation to glycaemic regulation in mice

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 1, 2014, Pages 31-41

  Modak, Manisha A ^a   Parab, P B ^b,c   Ghaskadbi, Saroj S ^a  

^a UNIVERSITY OF PUNE   (India)

^b NATIONAL CENTRE FOR CELL SCIENCE   (India)

^c APT Research Foundation ^*  (India)

Author keywords

Diabetes; Glycaemic regulation; Hyperglycaemia; Oxidative stress markers; Oxidative stress profile

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INSULIN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ASSAY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DNA DAMAGE; ENZYME ASSAY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HYPERGLYCEMIA; INSULIN TREATMENT; LIPID PEROXIDATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE LEVEL; TISSUE SPECIFICITY;

DIABETES; GLYCAEMIC REGULATION; HYPERGLYCAEMIA; OXIDATIVE STRESS MARKERS; OXIDATIVE STRESS PROFILE;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DNA DAMAGE; FEMALE; HYPERGLYCEMIA; LIPID PEROXIDATION; MALE; MICE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; STREPTOZOCIN;

EID: 84892474047     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2460     Document Type: Article

References (64)

1. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-673.
2. Sayre LM, Smith MA, Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr Med Chem 2001; 8: 721-738.
3. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 2003; 53: S26-S36.
4. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006; 52(4): 601-623.
5. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
7. Tamagisshi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med ell Longev 2010; 3(2): 101-108.
8. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010; 107: 1058-1070.
9. Gopaul NK, Anggard EE, Mallet AI, Betteridge DJ, Wolff SP, et al. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with NIDDM. FEBS Lett 1995; 368: 225-229.
10. Davy G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, et al. In vivo formation of 8-iso-prostaglandin F2a and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224-229.
11. Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 2002; 251: 69-76.
12. Astaneie F, Afshari M, Mojtahedi A, et al. Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients. Arch Med Res 2005; 36(4): 376-81.
13. Rahimi R, Nikfar S, Larijani B, Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomed Pharmacother 2005; 59: 365-373.
14. Brownlee M. The pathophysiology of diabetic complications. Diabetes 2005; 54: 1615-1625.
15. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006; 212: 167-178.
16. Noiri E, Tsukahara H. Parameters for measurement of oxidative stress in diabetes mellitus: applicability of enzyme-linked immunosorbent assay for clinical evaluation. J Invest Med 2005; 56(4): 167-75.
17. Ceriello A, Lush CW, Darsow T, et al. Maggs D pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes. Diabetes Metab Res Rev 2007; 24(2): 103-108.
18. Liao Y, Takashima S, Zhao H, et al. Control of plasma glucose with alpha-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice. Cardiovasc Res 2006; 70(1): 107-16.
19. Satoh N, Shimatsu A, Yamada K, et al. An alpha-glucosidase inhibitor, voglibose, reduces oxidative stress markers and soluble intercellular adhesion molecule 1 in obese type 2 diabetic patients. Metabolism 2006; 55(6): 786-93.
20. O'Brain RC, Alpers CE, Balazs N, Mercuri J. In vitro and in vivo antioxidant properties of gliclazide. J. of diabetes and its complications 2000; 14: 201-6.
21. Mutalik S, Chetana M, Sulochana B, Devi PU, Udupa N. Effect of dianex, a herbal formulation on experimentally induced diabetes mellitus. Phytother Res 2005; 19(5): 409-15.
22. Heath RL, Packer L. Effect of light on lipid peroxidation in chloroplasts. Biochem Biophys Res Commun 1965; 19: 716-20.
23. Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 2003; 329: 23-28.
24. Modak M, Parab P, Ghaskadbi S. Pancreatic islets are very poor in rectifying DNA damage. Pancreas 2009; 38: 23-9.
25. Hamilton ML, Guo ZM, Fuller CD, et al. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 2001; 29(10): 2117-2126.
26. Cardinal JW, Margison GP, Mynett KJ, Yates AP, Cameron DP, Elder R. Increased susceptibility to streptozotocin-induced B cell apoptosis and delayed autoimmune diabetes in alkylpurine-DNA-N-glycosylase-deficient mice. Mol Cell Biol 2001; 21: 5605-5613.
27. Aebi HZ. Catalase. In Methods of Enzymatic Analysis, vol 3, Bermeyer HU (ed). Verlagchemie GmbH: Weinhein, 1983; 277-282.
28. Beauchamp C, Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Anal Biochem 1971; 44: 276-287.
29. Goldberg DM, Spooner RJ. Glutathione reductase. In Methods of Enzymatic Analysis, vol 3, Bermeyer HU (ed). Verlagchemie GmbH: Weinhein, 1983; 258-265.
30. Lawrence RA, Burk RF. Glutathione peroxidase activity in selenium deficient rat liver. Biochem Biophys Res Commun 1976; 71: 952-958.
31. Teixeira HD, Meneghini R. Chinese hamster fibroblasts overexpressing CuZn-superoxide dismutase undergo a global reduction in antioxidants and an increasing sensitivity of DNA to oxidative damage. Biochem J 1996; 315: 821-825.
32. Kaneto H, Katakami N, Kawamori D, et al. Involvement of oxidative stress in the pathogenesis of diabetes. Antioxidants and redox signaling 2007; 9: 355-366.
33. Ceriello A, Bortolotti N, Motz E, Cresecntini A, Lizzio S, Russo A. Meal-generated oxidative stress in type 2 diabetes patients. Diabetic care 1998; 21: 1529-33.
34. Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L. Pomahacova R parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J diabetes Complications 2003; 17: 7-10.
35. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005; 43(2): 289-330.
36. Piarulli F, Sartore G, Ceriello A, et al. Lapolla relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients. Diabetologia 2009; 52: 1419-1425.
37. Wohaieb SA, Godin DV. Alterations in free radicals tissue-defense mechanisms in streptozotocin-induced diabetes in rat: effect of insulin treatment. Diabetes 1987; 36: 1014-1018.
38. Srivastava P, Saxena AK, Kale RK, Baquer NZ. Insulin like effects of lithium and vanadate on the altered antioxidant status of diabetic rats. Res Commun Chem Pathol Pharmacol 1993; 80: 283-293.
39. Kakar R, Kalra J, Mantha SV, Prasad K. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 1995; 151: 113-119.
40. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412.
41. Van Dam PS, Van Asbeck BS, Erkelens W, Marx JJM, Gispen WH, Bravenboer B. The role of oxidation stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995; 11: 181-192.
42. Kakkar R, Mantha SV, Kalra J, Parsad K. Time course study of oxidation stress in aorta and heart of diabetic rat. Clin Sci 1996; 91: 441-448.
43. De Angelis KLD, Cestaxi IA, Barp J, et al. Oxidative stress in the latissimus dorsi muscle of diabetic rats. Braz J Med Biol Rev 2000; 33: 1363-1368.
44. Genet S, Kale RK, Baquer NZ. Effect of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds. Mol Cell Biochem 2000; 210(1-2): 23-8.
45. Faure P, Cortlcelll P, Richard MJ, et al. Lipid peroxidation and trace element status in diabetic ketotic patients: influence of insulin therapy. Clin Chem 1993; 39(5): 789-793.
46. Bhor VM, Sivakami S. Regional variations in intestinal brush border membrane fluidity and function during diabetes and the role of oxidative stress and non-enzymatic glycation. Mol Cell Biochem 2003; 252(1-2): 125-32.
47. Quilliot D, Walters E, Bonte J, Fruchart JC, Duiez P, Ziegler O. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am J Clin Nutr 2005; 81: 1117-1125.
48. Saxena R, Madhu SV, Shukla R, Prabhu K, Ghambhir J. Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications. Clin Chim Acta 2005; 359: 101-108.
49. Hudson EK, Hogue B, Souza-Pinto N, et al. Age-associated change in mitochondrial DNA damage. Free Radic Res 1998; 29: 573-579.
50. Chance B, Sies S, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
51. Brown WM, George M Jr, Wilson AC. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci U S A 1979; 76: 1967-1971.
52. Brown WM, Prager EM, Wang A, Wilson AC. Mitochondrial DNA sequences of primates: tempo and mode of evolution. J Mol Evol 1982; 18: 225-239.
53. Clayton DA. Replication of mammalian mitochondrial DNA. Cell 1982; 28: 693-705.
54. Clayton DA. Transcription of the mammalian mitochondrial genome. Annu Rev Biochem 1984; 53: 573-594.
55. Brich-Machin MA. Using mitochondrial DNA as a biosensor of early cancer development. Br J Cancer 2005; 93(3): 271-273.
56. Marklund SL, Westman NG, Lundgren E, Roos G. Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res 1982; 42(5): 1955-61.
57. Bannister WH, Bannister AJ. Factor analysis of the activities of superoxide dismutase, catalase and glutathione peroxidase in normal tissues and neoplastic cell lines. Free Radic Res Commun 1987; 4(1): 1-13.
58. Avanzo JL, Mendonca CX Jr, Cesar MDC. Role of antioxidant systems in induced nutritional pancreatic atrophy in chick. Comp Biochem Physiol B Biochem Mol Biol 2002; 131: 815-823.
59. Sagara Y, Dargush R, Chambers D, Davis J, Schubert D, Maher P. Cellular mechanism of resistance to chronic oxidative stress. Free Radic Boil Med 1998; 24: 1375-1389.
60. Hellsten Y, Tullson PC, Richter EA, Bangsbo J. Oxidation of urate in human skeletal muscle during exercise. Free Radic Biol Med 1997; 22(1-2): 169-74.
61. Park KS, Kim JH, Kim MS, et al. Effects of insulin and antioxidant on plasma 8-hydroxyguanine and tissue 8-hydroxydeoxyguanosine in streptozotocin-induced diabetic rats. Diabetes 2001; 50: 2837-2841.
62. Koo JR, Vaziri ND. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 2003; 63: 195-201.
63. Paolisso G, Di Maro G, Pizza G, et al. Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 1992; 263: E435-40.
64. Paolisso G, D'Amore A, Giuliano D, et al. Pharmacologic dose of vitamin E improves insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 1993; 57: 650-6.